Virulence factors in pneumococcal respiratory pathogenesis

Future Microbiology

Volumn 3, Issue 2, 2008, Pages 205-221

  Preston, Julie A ^a   Dockrell, David H ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Bacteriocins; Competence; Oxidative stress; Pili; Pneumolysin; Polysaccharide capsule; Proteases; Streptococcus pneumoniae

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIOCIN; CELL SURFACE PROTEIN; ENDONUCLEASE; ENDOPEPTIDASE CLP; HYALURONIDASE; MYOCILIN; MYOCILIN 4; PNEUMOLYSIN; PROTEINASE; PYRUVATE OXIDASE; VIRULENCE FACTOR;

BACTERIAL COLONIZATION; BACTERIAL GENETICS; BACTERIAL METABOLISM; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM COMPETENCE; BACTERIUM MUTANT; BACTERIUM PILUS; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; QUORUM SENSING; RESPIRATORY TRACT INFECTION; REVIEW; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

HUMANS; MODELS, BIOLOGICAL; MUTATION; PNEUMONIA, PNEUMOCOCCAL; STREPTOCOCCUS PNEUMONIAE; VIRULENCE FACTORS;

STREPTOCOCCUS PNEUMONIAE;

EID: 47249148402     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460913.3.2.205     Document Type: Review

References (140)

1. Watson DA, Musher DM, Jacobson JW, Verhoef J: A brief history of the pneumococcus in biomedical research: a panoply of scientific discovery. Clin. Infect. Dis. 17, 913-924 (1993).
2. Bogaert D, De Groot R, Hermans PW: Streptoccus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect. Dis. 4, 144-154 (2004).
3. Ortqvist A, Hedlund J, Kalin M: Streptococcus pneumoniae: epidemiology, risk factors, and clinical features. Semin. Respir. Crit. Care Med. 26, 563-574 (2005).
4. Jacobs MR: Streptococcus pneumoniae: epidemiology and patterns of resistance. Am. J. Med. 117(Suppl. 3A), 3S-15S (2004).
5. Whitney CG, Farley MM, Hadler J et al.: Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348, 1737-1746 (2003).
6. Hicks LA, Harrison LH, Flannery B et al.: Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J. Infect. Dis. 196, 1346-1354 (2007).
7. Morsczeck C, Prokohova T, Sigh J et al.: Streptococcus pneumoniae: proteomics of surface proteins for vaccine development. Clin. Microbiol. Infect. 14, 74-81 (2008).
8. Tettelin H, Nelson KE, Paulsen IT et al.: Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science 293, 498-506 (2001).
9. Avery OT, MacLeod CM, McCarty M: Studies on the chemical nature of the substrate inducing transofrmation of pneumococcal types: indcution of transformation by a desoxyribnucleic acid fraction isolated from the pneumococcus type III. J. Exp. Med. 79, 137-158 (1944).
10. Prudhomme M, Attaiech L, Sanchez G, Martin B, Claverys JP: Antibiotic stress induces genetic transformability in the human pathogen Streptococcus pneumoniae. Science 313, 89-92 (2006).
11. Ehrlich GD, Hu FZ, Shen K, Stoodley P, Post JC: Bacterial plurality as a general mechanism driving persistence in chronic infections. Clin. Orthop. Relat. Res. 20-24 (2005).
12. Hiller NL, Janto B, Hogg JS et al.: Comparative genomic analyses of seventeen Streptococcus pneumoniae strains: insights into the pneumococcal supragenome. J. Bacteriol. 189, 8186-8195 (2007).
13. Sjostrom K, Spindler C, Ortovist A et al.: Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen. Clin. Infect. Dis. 42, 451-459 (2006).
14. Brueggemann AB, Peto TE, Crook DW, Butler JC, Kristinsson KG, Spratt BG: Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J. Infect. Dis. 190, 1203-1211 (2004).
15. Obert C, Sublett J, Kaushal D et al.: Identification of a candidate Streptococcus pneumoniae core genome and regions of diversity correlated with invasive pneumococcal disease. Infect. Immun. 74, 4766-4777 (2006).
16. Dagerhamn J, Blomberg C, Browall S, Sjostrom K, Morfeldt E, Henriques-Normark B: Pattern of accessory genes predicts the same relatedness among strains of Streptococcus pneumoniae as sequencing house keeping genes: a novel approach in molecular epidemiology. J. Clin. Microbiol. DOI 10.1128/JCM.01438-07 (2007) (Epub ahead of print).
17. Silva NA, McCluskey I, Jefferies JM et al.: Genomic diversity between strains of the same serotype and multilocus sequence type among pneumococcal clinical isolates. Infect. Immun. 74, 3513-3518 (2006).
18. Sjostrom K, Blomberg C, Fernebro J et al.: Clonal success of piliated penicillin nonsusceptible pneumococci. Proc. Natl Acad Sci. USA 104, 12907-12912 (2007).
19. Lee KJ, Bae SM, Lee MR, Yeon SM, Lee YH, Kim KS: Proteomic analysis of growth phase-dependent proteins of Streptococcus pneumoniae. Proteomics 6, 1274-1282 (2006),
20. Ko KS, Park S, Oh WS et al.: Comparative analysis of growth-phase-dependent gene expression in virulent and avirulent Streptococcus pneumoniae using a high-density DNA microarray. Mol. Cells 21, 82-88 (2006).
21. Bae SM, Yeon SM, Kim TS, Lee KJ: The effect of protein expression of Streptococcus pneumoniae by blood. J. Biochem. Mol. Biol. 39, 703-708 (2006).
22. Orihuela CJ, Radin JN, Sublett JE, Gao G, Kaushal D, Tuomanen EI: Microarray analysis of pneumococcal gene expression during invasive disease. Infect. Immun. 72, 5582-5596 (2004).
23. Park IH, Pritchard DG, Cartee R, Brandao A, Brandileone MC, Nahm MH: Discovery of a new capsular serotype (6C) within serogroup 6 of Streptacoccus pneumoniae. J. Clin. Microbiol. 45, 1225-1233 (2007).
24. Morona JK, Morona R, Paton JC: Attachment of capsular polysaccharide to the cell wall of Streptococcus pneumoniae type 2 is required for invasive disease. Proc. Natl Acad. Sci. USA 103, 8505-8510 (2006).
25. Morona JK, Paton JC, Miller DC, Morona R: Tyrosine phosphorylation of CpsD negatively regulates capsular polysaccharide biosynthesis in Streptococcus pneumoniae. Mol. Microbiol. 35, 1431-1442 (2000).
26. Morona JK, Morona R, Miller DC, Paton JC: Streptococcus pneumoniae capsule biosynthesis protein CpsB is a novel manganese-dependent phosphotyrosine-protein phosphatase. J. Bacteriol. 184, 577-583 (2002).
27. Morona JK, Miller DC, Morona R, Paton JC: The effect that mutations in the conserved capsular polysaccharide biosynthesis genes cpsA, cpsB, and cpsD have on virulence of Streptococcus pneumoniae. J. Infect. Dis. 189, 1905-1913 (2004).
28. Jonsson S, Musher DM, Chapman A, Goree A, Lawrence EC: Phagocytosis and killing of common bacterial pathogens of the lung by human alveolar macrophages. J. Infect. Dis. 152, 4-13 (1985).
29. Ali F, Lee ME, Iannelli F et al.: Streptococcus pneumoniae-associated human macrophage apoptosis after bacterial internalization via complement and Fcgamma receptors correlates with intracellular bacterial load. J. Infect. Dis. 188, 1119-1131 (2003).
30. Nelson AL, Roche AM, Gould JM, Chim K, Ratner AJ, Weiser JN: Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance. Infect. Immun. 75, 83-90 (2007).
31. Weiser JN, Austrian R, Sreenivasan PK, Masure HR: Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect. Immun. 62, 2582-2589 (1994).
32. Kim JO, Weiser JN: Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J. Infect. Dis. 177, 368-377 (1998).
33. Barocchi MA, Ries J, Zogaj X et al.: A pneumococcal pilus influences virulence and host inflammatory responses. Proc. Natl Acad. Sci. USA 103, 2857-2862 (2006).
34. Schwarz-Linek U, Hook M, Potts JR: The molecular basis of fibronectin-mediated bacterial adherence to host cells. Mol. Microbiol. 52, 631-641 (2004).
35. Gianfaldoni C, Censini S, Hilleringmann M et al.: Streptococcus pneumoniae pilus subunits protect mice against lethal challenge. Infect. Immun. 75, 1059-1062 (2007).
36. Sandgren A, Albiger B, Orihuela CJ, Tuomanen E, Normark S, Henriques-Normark B: Virulence in mice of pneumococcal clonal types with known invasive disease potential in humans. J. Infect. Dis. 192, 791-800 (2005).
37. Basset A, Trzcinski K, Hermos C et al.: Association of the pneumococcal pilus with certain capsular serotypes but not with increased virulence. J. Clin. Microbiol. 45, 1684-1689 (2007).
38. Oggioni MR, Trappetti C, Kadioglu A et al.: Switch from planktonic to sessile life: a major event in pneumococcal pathogenesis. Mol. Microbiol. 61, 1196-1210 (2006).
39. Jedrzejas MJ: Pneumococcal virulence factors: structure and function. Microbiol. Mol. Biol. Rev. 65, 187-207 (2001).
40. Manco S, Hernon F, Yesilkaya H, Paton JC, Andrew PW, Kadioglu A: Pneumococcal neuraminidases A and B both have essential roles during infection of the respiratory tract and sepsis. Infect. Immun, 74, 4014-4020 (2006).
41. Soong G, Muir A, Gomez MI et al.: Bacterial neuraminidase facilitates mucosal infection by participating in biofilm production. J. Clin. Invest. 116, 2297-2305 (2006).
42. Hall-Stoodley L, Hu FZ, Gieseke A et al.: Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 296, 202-211 (2006).
43. McCullers JA, Bartmess KC: Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J Infect. Dis. 187, 1000-1009 (2003).
44. Shakhnovich EA, King SJ, Weiser JN: Neuraminidase expressed by Streptococcus pneumoniae desialylates the lipopolysaccharide of Neisseria meningitidis and Haemophilus Influenzae: a paradigm for interbacterial competition among pathogens of the human respiratory tract. Infect. Immun. 70, 7161-7164 (2002).
45. Blue CE, Paterson GK, AR Kerr, Berge M, Claverys JP, Mitchell TJ: ZmpB, a novel virulence factor of Streptcoccus pneumoniae that induces tumor necrosis factor alpha production in the respiratory tract. Infect. Immun. 71, 4925-4935 (2003).
46. Oggioni MR, Memmi G, Maggi T, Chiavolini D, Iannelli F, Pozzi G: Pneumococcal zinc metalloproteinase ZmpC cleaves human matrix metalloproteinase 9 and is a virulence factor in experimental pneumonia. Mol Microbiol. 49, 795-805 (2003).
47. Kilian M, Mestecky J, Kulhavy R, Tomana, M, Butler WT. IgA1 proteases from Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, and Streptococcus sanguis. comparative immunochemical studies. J. Immunol. 124, 2596-600 (1980).
48. Weiser JN, Bae D, Fasching C, Scamurra RW, AJ Ratner, Janoff EN: Antibody-enhanced pneumococcal adherence requires IgA1 protease. Proc. Natl Acad. Sci. USA 100, 4215-4220 (2003).
49. Fasching CE, Grossman T, Corthesy B, Plaut AG, Weiser JN, Janoff EN: Impact of the molecular form of immunoglobulin A on functional activity in defense against Streptococcus pneumoniae. Infect. Immun. 75, 1801-1810 (2007).
50. Tu AH, Fulgham RL, McCrory MA, Briles DE, Szalai AJ: Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae. Infect. Immun. 67, 4720-4724 (1999).
51. Yuste J, Botto M, Paton JC, Holden DW, Brown JS: Additive inhibition of complement deposition by pneumolysin and PspA facilitates Streptococcus pneumoniae septicemia. J Immunol. 175, 1813-1819 (2005).
52. Graham RM, Paton JC: Differential role of CbpA and PspA in modulation of in vitro CXC chemokine responses of respiratory epithelial cells to infection with Streptococcus pneumoniae. Infect. Immun. 74, 6739-6749 (2006).
53. Zhang JR, Mostov KE, Lamm ME et al.: The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell 102, 827-837 (2000).
54. Elm C, Braathen R, Bergmann S et al.: Ectodomains 3 and 4 of human polymeric Immunoglobulin receptor (hpIgR) mediate invasion of Streptococcus pneumoniae into the epithelium. J. Biol. Chem. 279, 6296-6304 (2004).
55. Sun K, Johansen FE, Eckmann L, Metzger DW: An important role for polymeric Ig receptor-mediated transport of IgA in protection against Streptococcus pneumoniae nasopharyngeal carriage. J. Immunol. 173, 4576-4581 (2004).
56. Cundell DR, Gerard NP, Gerard C, Idapaan-Heikkila I, Tuomanen EI: Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 377, 435-438 (1995).
57. Hammerschmidt S, Talay SR, Brandtzaeg P, Chhatwal GS: SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component. Mol. Microbiol. 25, 1113-1124 (1997).
58. Jarva H, Janulczyk R, Hellwage J, Zipfel PF, Bjorck L, Meri S: Streptococcus pneumoniae evades complement attack and opsonophagocytosis by expressing the pspC locus-encoded Hic protein that binds to short consensus repeats 8-11 of factor H. J. Immunol. 168, 1886-1894 (2002).
59. Lu L, Ma Y, Zhang JR: Streptococcus pneumoniae recruits complement factor H through the amino terminus of CbpA. J. Biol. Chem. 281, 15464-15474 (2006).
60. Kerr AR, Paterson GK, McCluskey J et al.: The contribution of PspC to pneumococcal virulence varies between strains and is accomplished by both complement evasion and complement-independent mechanisms. Infect. Immun. 74, 5319-5324 (2006).
61. Ogunniyi AD, LeMessurier KS, Graham RM et al.: Contributions of pneumolysin, pneumococcal surface protein A (PspA), and PspC to pathogenicity of Streptococcus pneumoniae D39 in a mouse model. Infect. Immun. 75, 1843-1851 (2007).
62. Iannelli F, Chiavolini D, Ricci S, Oggioni MR, Pozzi G: Pneumococcal surface protein C contributes to sepsis caused by Streptococcus pneumoniae in mice. Infect. Immun. 72, 3077-3080 (2004).
63. Orihuela CJ, Gao G, Francis KP Yu J, Tuomanen EI: Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. Infect. Dis. 190, 1661-1669 (2004).
64. Balachandran P, Brooks-Walter A, Virolainen-Julkunen A, Hollingshead SK, Briles DE: Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae. Infect. Immun. 70, 2526-2534 (2002).
65. Berry AM, Paton JC: Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins. Infect. Immun. 68, 133-140 (2000).
66. Mann B, Orihuela C, Antikainen J et al.: Multifunctional role of choline binding protein G in pneumococcal pathogenesis. Infect. Immun. 74, 821-829 (2006).
67. Holmes AR, McNab R, Minsap KW et al.: The pavA gene of Streptococcus pneumoniae encodes a fibronectin-binding protein that is essential for virulence. Mol. Microbiol. 41, 1395-1408 (2001).
68. Pracht D, Elm C, Gerber J et al.: PavA of Streptococcus pneumoniae modulates adherence, invasion, and meningeal inflammation. Infect Immun. 73, 2680-2689 (2005).
69. Geoffroy C, Mengaud J, Alouf JE, Cossart P: Alveolysin, the thiol-activated toxin of Bacillus alvei, is homologous to listeriolysin O, perfringolysin O, pneumolysin, and streptolysin O and contains a single cysteine. J. Bacteriol. 172, 7301-7305 (1990).
70. Johnson MK, Geoffroy C, Alouf JE: Binding of cholesterol by sulfhydryl-activated cytolysins. Infect. Immun. 27, 97-101 (1980).
71. Walker JA, Allen RL, Falmagne P, Johnson MK, Boulnois GJ: Molecular cloning, characterization, and complete nucleotide sequence of the gene for pneumolysin, the sulfhydryl-activated toxin of Streptococcus pneumaniae. Infect. Immun. 55, 1184-1189 (1987).
72. Tomasz A, Albino A, Zanati E: Multiple antibiotic resistance in a bacterium with suppressed autolytic system. Nature 227, 138-140 (1970).
73. Mosser JL, Tomasz A: Choline-containing teichoic acid as a structural component of pneumococcal cell wall and its role in sensitivity to lysis by an autolytic enzyme. J Biol. Chem. 245, 287-298 (1970).
74. Mitchell TJ, Alexander JE, Morgan PJ, Andrew PW: Molecular analysis of virulence factors of Streptococcus pneumoniae. Soc. Appl. Bacteriol. Symp. Ser. 26, 62S-71S (1997).
75. Balachandran P, Honingshead SK, Paton JC, Briles DE: The autolytic enzyme LytA of Streptococcus pneumoniae is not responsible for releasing pneumolysin. J. Bacteriol. 183, 3108-3116 (2001).
76. Guiral S, Mitchell TJ, Martin B, Claverys JP: Competence-programmed predation of noncompetent cells in the human pathogen Streptococcus pneumoniae: genetic requirements. Proc. Natl Acad. Sci. USA 102, 8710-8715 (2005).
77. Ibrahim YM, Kerr AR, Silva NA, Mitchell TJ: Contribution of the ATP-dependent protease C1pCP to the autolysis and virulence of Streptococcus pneumaniae. Infect. Immun. 73, 730-740 (2005).
78. Rogers PD, Thornton J, Barker KS et al.: Pneumolysin-dependent and -independent gene expression identified by cDNA microarray analysis of THP-1 human mononuclear cells stimulated by Streptococcus pneumoniae. Infect. Immun. 71, 2087-2094 (2003).
79. Hamon MA, Batsche E, Regnault B et al.: Histone modifications induced by a family of bacterial toxins. Proc. Natl Acad. Sci. USA 104, 13467-13472 (2007).
80. Rubins JB, Charboneau D, Fasching C et al.: Distinct roles for pneumolysin's cytotoxic and complement activities in the pathogenesis of pneumococcal pneumonia. Am. J. Res. Respir. Crit. Care Med. 153, 1339-1346 (1996).
81. Tilley SJ, Orlova EV, Gilbert RJ, Andrew PW, Saibil HR: Structural basis of pore formation by the bacterial toxin pneumolysin. Cell 121, 247-56 (2005).
82. Maus UA, Srivastava M, Paton JC et al.: Pneumolysin-induced lung injury is independent of leukocyte trafficking into the alveolar space. J. Immunol. 173, 1307-1312 (2004).
83. Lim JH, Stirling B, Derry J et al.: Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumaniae infections. Immunity 27, 349-360 (2007).
84. Cockeran R, Theron AJ, Feldman C, Mitchel TJ, Anderson R: Pneumolysin potentiates oxidative inactivation of alpha-1-proteinase inhibitor by activated human neutrophils. Respir. Med. 98, 865-871 (2004).
85. Rijneveld AW, van den Dobbelsteen GP, Florquin S et al.: Roles of interleukin-6 and macrophage inflammatory protein-2 in pneumolysin-induced lung inflammation in mice. J. Infect. Dis. 185, 123-126 (2002).
86. Maus UA, Backi M, Winter C et al.: Importance of phosphoinositide 3-kinase gamma in the host defense against pneumococcal infection. Am. J. Respir. Crit. Care Med. 175, 958-966 (2007).
87. Thornton J, McDaniel LS: THP-1 monocytes up-regulate intercellular adhesion molecule 1 in response to pneumolysin from Streptococcus pnuemoniae. Infect. Immun. 73, 6493-6498 (2005).
88. Colino J, Snapper CM: Two distinct mechanisms for induction of dendritic cell apoptosis in response to intact Streptococcus pneumoniae. J. Immunol. 174, 2354-2365 (2003).
89. Ratner AJ, Hippe KR, Aguilar IL, Bender MH, Nelson AL, Weiser JN: Epithelial cells axe sensitive detectors of bacterial pore-forming toxins. J. Biol. Chem. 281, 12994-12998 (2006).
90. Ratner AJ, Lysenko ES, Paul MN, Weiser JN: Synergistic proinflammatory responses induced by polymicrobial colonization of epithelial surfaces. Proc. Natl Acad. Sci. USA 102, 3429-3434 (2005).
91. Ratner AJ, Aguilar JL, Shchepetov M, Lysenko ES, Weiser IN: Nod1 mediates cytoplasmic sensing of combinations of extracellular bacteria. Cell Microbiol. 9, 1343-1351 (2007).
92. Cockeran R, Durandt C, Feldman C, Mitchell TJ, Anderson R: Pneumolysin activates the synthesis and release of interleukin-8 by human neutrophils in vitro. J. Infect. Dis. 186, 562-565 (2002).
93. Jefferies JM, Johnston CH, Kirkham LA et al.: Presence of nonhemolytic pneumolysin in serotypes of Streptococcus pneumoniae associated with disease outbreaks. J. Infect. Dis. 196, 936-944 (2007).
94. Jounblat R, Kadioglu A, Mitchell TJ, Andrew PW: Pneumococcal behavior and host responses during bronchopneumonia are affected differently by the cytolytic and complement-activating activities of pneumolysin. Infect. Immun. 71, 1813-1819 (2003).
95. Malley R, Henneke P, Morse SC et al.: Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl Acad. Sci. USA 100, 1966-1971 (2003).
96. Kadioglu A, Coward W, Colston MJ, Hewitt CR, Andrew PW: CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection. Infect. Immun. 72, 2689-2697 (2004).
97. Baba H, Kawamura I, Kohda C et al.: Induction of gamma interferon and nitric oxide by truncated pneumolysin that lacks pore-forming activity. Infect. Immun. 70, 107-113 (2002).
98. Srivastava A, Henneke P, Visintin A et al.: The apoptotic response to pneumolysin is Toll-like receptor 4 dependent and protects against pneumococcal disease. Infect. Immun. 73, 6479-6487 (2005).
99. Ha U, Lim JH, Jono H et al. A novel role for IκB kinase WN a and IKKβ in ERK-dependent up-regulation of MUC5AC mucin transcription by Streptococcus pneumoniae. J. Immunol. 178, 1736-1747 (2007).
100. Mindich L: Bacteriocins of Diplococcus pneumoniae. I. Antagonistic relationships and genetic transformations. J. Bacteriol. 92, 1090-1098 (1966).
101. Lux T, Nuhn M, Hakenbeck R, Reichmann P: Diversity of bacteriocins and activity spectrum in Streptococcus pneumoniae. J. Bacteriol. 189, 7741-7751 (2007).
102. Dawid S, Roche AM, Weiser JN: The blp bacteriocins of Streptococcus pneumoniae mediate intraspecies competition both in vitro and in vivo. Infect. Immun. 75, 443-451 (2007).
103. de Saizieu A, Gardes C, Flint N et al.: Microarray-based identification of a novel Streptococcus pneumoniae regulon controlled by an autoinduced peptide. J. Bacteriol. 182, 4696-4703 (2000).
104. Claverys JP, Havarstein LS: Extracellular-peptide control of competence for genetic transformation in Streptococcus pneumoniae. Front Biosci. 7, D1798-D1814 (2002).
105. Havarstein LS, Coomaraswamy G, Morrison DA: An unmodified heptadecapeptide pheromone induces competence for genetic transformation in Streptococcus pneumoniae. Proc. Natl Acad. Sci. USA 92, 11140-11144 (1995).
106. Havarstein LS, Martin B, Johnsborg O, Granadel C, Claverys JP: New insights into the pneumococcal fratricide: relationship to clumping and identification of a novel immunity factor. Mol. Microbiol. 59, 1297-1307 (2006).
107. Kreth J, Merritt J, Shi W, Qi F: Co-ordinated bacteriocin production and competence development: a possible mechanism for taking up DNA from neighbouring species. Mol. Microbiol. 57, 392-404 (2005).
108. Moscoso M, Claverys JP: Release of DNA into the medium by competent Streptococcus pneumoniae: kinetics, mechanism and stability of the liberated DNA. Mol. Microbiol. 54, 783-794 (2004).
109. Kausmally L, Johnsborg O, Lunde M, Knutsen E, Havarstein LS: Choline-binding protein D (CbpD) in Streptococcus pneumoniae is essential for competence-induced cell lysis. J. Bacteriol. 187, 4338-4435 (2005).
110. Steinmoen H, Knutsen E, Havarstein LS: Induction of natural competence in Streptococcus pneumoniae triggers lysis and DNA release from a subfraction of the cell population. Proc. Natl Acad. Sci. USA 99, 7681-7686 (2002).
111. Rodriguez-Cerrato V, Garcia P, Huelves L et al.: Pneumococcal LytA autolysin, a potent therapeutic agent in experimental peritonitis-sepsis caused by highly betalactam-resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 51, 3371-3373 (2007).
112. Moscoso M, Garcia E, Lopez R: Biofilm formation by Streptococcus pneumoniae: role of choline, extracellular DNA, and capsular polysaccharide In microbial accretion. J. Bacteriol. 188, 7785-7795 (2006).
113. Sun J, Daniel R, Wagner-Dobler I, Zeng AP: Is autoinducer-2 a universal signal for interspecies communication: a comparative genomic and phylogenetic analysis of the synthesis and signal transduction pathways. BMC Evol. Biol. 4, 36 (2004).
114. Stroeher UH, Paton AW, Ogunniyi AD, Paton JC: Mutation of luxS of Streptococcus pneumoniae affects virulence in a mouse model. Infect. Immun. 71, 3206-3212 (2003).
115. Romao S, Memmi G, Oggioni MR, Trombe MC: LuxS impacts on LytA- dependent autolysis and on competence in Streprococcus pneumoniae. Microbiology 152, 333-341 (2006).
116. Joyce EA, Kawale A, Censini, S, Kim CC, Covacci A, Falkow S: LuxS is required for persistent pneumococcal carriage and expression of virulence and biosynthesis genes. Infect. Immun. 72, 2964-2975 (2004).
117. Albiger B, Dahlberg S, Sandgren A et al.: Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection. Cell Microbiol. 9, 633-644 (2007).
118. Brinkmann V, Reichard U, Goosmann C et al.: Neutrophil extracellular traps kill bacteria. Science 303, 1532-1535 (2004).
119. Wartha F, Beiter K, Albiger B et al.: Capsule and D-alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps. Cell Microbiol. 9, 1162-1171 (2007).
120. Better K, Wartha F, Albiger B, Normark S, Zychlinsky A, Henriques-Normark B: An endonuclease allows Streptococcus pneumoniae to escape from neutrophil extracellular traps. Curr. Biol. 16, 401-407 (2006).
121. Kovacs M, Halfmann A, Fedtke I et al.: A functional dlt operon, encoding proteins required for incorporation of D-alanine in teichoic acids in Gram-positive bacteria, confers resistance to cationic antimicrobial peptides in Streptococcus pneumoniae. J. Bacteriol. 188, 5797-5805 (2006).
122. Pericone CD, Overweg K, Hermans PW, Weiser JN: Inhibitory and bactericidal effects of hydrogen peroxide production by Streptococcus pneumoniae on other inhabitants of the upper respiratory tract. Infect. Immun. 68, 3990-3997 (2000).
123. Duane PG, Rubins A Weisel HR, Janoff EN: Identification of hydrogen peroxide as a Streptococcus pneumoniae toxin for rat alveolar epithelial cells. Infect. Immun. 61, 4392-4397 (1993).
124. Yesilkaya H, Kadioglu A, Gingles N, Alexander JE, Mitchell TJ, Andrew PW: Role of manganese-containing superoxide dismutase in oxidative stress and virulence of Streptococcus pneumoniae. Infect. Immun. 68, 2819-2826 (2000).
125. Tseng HJ, McEwan AG, Paton JC, Jennings MP: Virulence of Streptococcus pneumoniae: PsaA mutants are hypersensitive to oxidative stress. Infect. Immun. 70, 1635-1639 (2002).
126. Pericone CD, Park S, Imlay A Weiser JN: Factors contributing to hydrogen peroxide resistance in Streptococcus pneumoniae include pyruvate oxidase (SpxB) and avoidance of the toxic effects of the fenton reaction. J. Bacteriol. 185, 6815-6825 (2003).
127. Regev-Yochay G, Trzcinski K, Thompson CM, Lipsitch M, Malley R: SpxB is a suicide gene of Steptococcus pneumoniae and confers a selective advantage in an in vivo competitive colonization model. J. Bacteriol. 189, 6532-6539 (2007).
128. Regev-Yochay G, Trzcinski K, Thompson CM, Malley R, Lipsitch M: Interference between Streptococcus pneumoniae and Staphylococcus aureus: In vitro hydrogen peroxide-mediated killing by Streptococcus pneumoniae. J Bacteriol. 188, 4996-5001 (2006).
129. Paterson GK, Blue CE, Mitchell TJ: An operun in Streptococcus pneumoniae containing a putative alkylhydroperoxidase D homologue contributes to virulence and the response to oxidative stress. Microb. Pathog. 40, 152-160 (2006).
130. Kwon HY, Kim SW, Choi MH et al.: Effect of heat shock and mutations in C1pL and C1pP on virulence gene expression in Streptococcus pneumoniae. Infect. Immun. 71, 3757-3765 (2003).
131. Kwon HY, Ogunniyi AD, Choi MH, Pyo SN, Rhee DK, Paton JC: The C1pP protease of Streptococcus pneumoniae modulates virulence gene expression and protects against fatal pneumococcal challenge. Infect. Immun. 72, 5646-5653 (2004).
132. Robertson GT, Ng WL, Foley J, Gilmour R, Winkler ME: Global transcriptional analysis of c1pP mutations of type 2 Streptococcus pneumoniae and their effects on physiology and virulence. J Bacteriol. 184, 3508-3520 (2002).
133. Tu le N, Jeong HY, Kwon HY et al.: Modulation of adherence, invasion, and tumor necrosis factor alpha secretion during the early stages of infection by Streptococcus pneumoniae C1pL. Infect. Immun. 75, 2996-3005 (2007).
134. Ponnuraj K, Jedrzejas MJ: Mechanism of hyaluronan binding and degradation: structure of Streptococcus pneumoniae hyaluronate lyase in complex with hyaluronic acid disaccharide at 1.7 A resolution. J. Mol. Biol. 299, 885-895 (2000).
135. Jedrzejas MJ: Unveiling molecular mechanisms of bacterial surface proteins: Streatacoccus pneumoniae as a model organism for structural studies. Cell Mol. Life Sci. 64(21), 2799-2822 (2007).
136. Feldman C, Cockeran R, Jedrzejas MJ, Mitchell TJ, Anderson R: Hyaluronidase augments pneumolysin-mediated injury to human ciliated epithelium. Int J. Infect. Dis. 11, 11-15 (2007).
137. Hava DL, Camilli A: Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol. Microbiol. 45, 1389-1406 (2002).
138. King SJ, Hippe KR, Weiser JN: Deglycosylation of human glycoconjugates by the sequential activities of exoglycosidases expressed by Streptococcus pneumoniae. Mol. Microbiol. 59, 961-974 (2006).
139. Bongaerts RJ, Heinz HE Hadding U, Zysk G: Antigenicity, expression, and molecular characterization of surface-located pullulanase of Streptococcus pneumoniae. Infect. Immun. 68, 7141-7143 (2000).
140. van Bueren AL, Higgins M, Wang D, Burke RD, Boraston AB: Identification and structural basis of binding to host lung glycogen by streptococcal virulence factors. Nat. Struct. Mol. Biol. 14, 76-84 (2007).